Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study

PURPOSE: Cutaneous melanoma is among the fastest growing malignancies in Norway and ultraviolet radiation (UVR) exposure is the primary environmental risk factor. Immunomodulating drugs can increase skin photosensitivity and suppress immune responses, and by such mechanisms influence melanoma risk....

Descripción completa

Detalles Bibliográficos
Autores principales: Berge, Leon Alexander Mclaren, Andreassen, Bettina Kulle, Stenehjem, Jo Steinson, Heir, Trond, Karlstad, Øystein, Juzeniene, Asta, Ghiasvand, Reza, Larsen, Inger Kristin, Green, Adele C, Veierød, Marit Bragelien, Robsahm, Trude Eid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755337/
https://www.ncbi.nlm.nih.gov/pubmed/33376408
http://dx.doi.org/10.2147/CLEP.S269446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755337/
https://www.ncbi.nlm.nih.gov/pubmed/33376408
http://dx.doi.org/10.2147/CLEP.S269446

Ejemplares similares